arrow
W

Werner Heinz

humboldt university of berlin
H指数:45
被引数:9,565

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Anti-infective vaccination strategies in patients with haematological malignancies or solid tumours: updated guideline of the Infectious Diseases Working Party of the German Society for Hematology and Medical Oncology

血液病或实体瘤患者的抗感染疫苗接种策略:德国血液学与肿瘤学学会感染性疾病工作组更新指南

2026-03-300
PRE
Molecular diagnostics in cancer patients with suspected respiratory mold infections

癌症患者中疑似呼吸道霉菌感染时的分子诊断

2025-11-010
PRE
Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)

血液系统恶性肿瘤患者侵袭性真菌病的初级预防: 德国血液和医学肿瘤学会 (DGHO) 传染病工作组 (AGIHO) 建议的2022更新

2023-06-1346
OAAI
Empiric vs Preemptive Antifungal Strategy in High-Risk Neutropenic Patients on Fluconazole Prophylaxis: A Randomized Trial of the European Organization for Research and Treatment of Cancer
2022-07-3036
OAAI
Management of herpesvirus reactivations in patients with solid tumours and hematologic malignancies: update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) on herpes simplex virus type 1, herpes simplex virus type 2, and varicella zoster virus

实体瘤和血液系统恶性肿瘤患者疱疹病毒再激活的管理: 德国血液和医学肿瘤学会 (DGHO) 感染性疾病工作组 (AGIHO) 关于1型单纯疱疹病毒、2型单纯疱疹病毒和水痘带状疱疹病毒的指南更新

2022-01-0734
OAAI
Bendamustine followed by ofatumumab and ibrutinib in chronic lymphocytic leukemia: primary endpoint analysis of a multicenter, open-label, phase II trial (CLL2-BIO)
2020-02-2715
OAAI
Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn)
2019-08-0829
PREAI
Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors-Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO)
2018-06-0164
OAAI
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

曲霉菌病的诊断和管理: 2017 escmid-ecmm-ers指南的执行摘要

2018-05-01862
OAAI
A Comparison of Aspergillus and Mucorales PCR Testing of Different Bronchoalveolar Lavage Fluid Fractions from Patients with Suspected Invasive Pulmonary Fungal Disease
2018-02-0126
OAAI
Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease (vol 72, pg 3406, 2017)
2017-10-037
OAAI
Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
2017-08-30114
OAAI
Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease
2017-08-0965
OAAI
Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study
2016-10-0181
OAAI
CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

血液系统疾病 (包括异基因干细胞移植) 患者的中枢神经系统感染-德国血液学和医学肿瘤学会 (DGHO) 传染病工作组 (AGIHO) 指南

2016-07-0163
OAAI
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis
2016-07-01506
PREAI